Skip to main content

Advertisement

SpringerLink
Log in

Approaches to the diagnosis of hepatocellular carcinoma

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

The advent of screening programs for hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis has resulted in detection of smaller and smaller lesions in the liver. Some of these are small carcinomas, but many are not malignant in nature or are potential precursors to malignancy. Neither radiology nor biopsy can be used confidently to distinguish between these possibilities when the lesions are smaller than approximately 1.5 cm in diameter. Therefore, diagnostic algorithms must be developed to assist physicians in investigating these small lesions and deciding when they are truly malignant, when treatment is necessary, or whether a watchful waiting course is appropriate. The diagnostic difficulties are presented, with examples of diagnostic algorithms that may be helpful in managing these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Valls C, Cos M, Figueras J, et al.: Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 2004, 182:1011–1017.

    PubMed  Google Scholar 

  2. Lim JH, Kim CK, Lee WJ, et al.: Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000, 175:693–698.

    PubMed  CAS  Google Scholar 

  3. Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP: Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers. Abdom Imaging 2003, 28:333–346.

    Article  PubMed  CAS  Google Scholar 

  4. Krinsky GA, Lee VS, Theise ND, et al.: Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001, 219:445–454.

    PubMed  CAS  Google Scholar 

  5. Ito K, Fujita T, Shimizu A, et al.: Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol 2004, 183:699–705.

    PubMed  Google Scholar 

  6. Shimizu A, Ito K, Koike S, et al.: Cirrhosis or chronic hepatitis: evaluation of small (< or=2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003, 226:550–555.

    Article  PubMed  Google Scholar 

  7. Jeong YY, Mitchell DG, Kamashima T: Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR. imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 2002, 178:1327–1334.

    PubMed  Google Scholar 

  8. Theise ND, Park YN, Kojiro M: Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002, 6:497–512. A good description of the progression of morphology from benign to malignant.

    Article  PubMed  Google Scholar 

  9. Thiese ND, Schwartz M, Miller C, Thung SN: Macroregenerative nodules and hepatocellular carcinoma in 44 sequential adult liver explants with cirrhosis. Hepatology 1992, 16:949–955.

    Article  Google Scholar 

  10. Furuya K, Nakamura M, Yamamoto T, et al.: Macroregenerative nodules of the liver: a clinicopathological study of 345 autopsy cases of chronic liver disease. Cancer 1988, 61:99–105.

    Article  PubMed  CAS  Google Scholar 

  11. Borzio M, Fargion S, Borsio F, et al.: Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocelularc carcinoma development. J Hepatol 2003, 39:208–214.

    Article  PubMed  Google Scholar 

  12. Aihara T, Noguchi S, Sasaki Y, et al.: Clonal analysis of precancerous lesion of hepatocellular carcinoma. Gastroenterology 1996, 111:455–461.

    Article  PubMed  CAS  Google Scholar 

  13. Paradis V, Laurendeau I, Vidaud M, Bedossa P: Clonal analysis of macronodules in cirrhosis. Hepatology 1988, 28:953–958.

    Article  Google Scholar 

  14. Theise ND: Macroregenerative (dysplastic nodules) and hepatocarcinogenesis: theoretical and clinical considerations. Semin Liver Dis 1995, 15:360–371.

    PubMed  CAS  Google Scholar 

  15. Watanabe S, Okita K, Harada T, et al.: Morphologic studies of liver cell dysplasia. Cancer 1983, 33:2197–205.

    Article  Google Scholar 

  16. Terada T, Nakanuma Y, Hso M, et al.: Fatty macroregenerative nodule in non-steatotic liver cirrhosis: a morphologic study. Virchow Arch Pathol Anat Histopathol 1989, 415:131–136.

    Article  CAS  Google Scholar 

  17. Krinsky G, Thiese N, Rofsky N, et al.: Dysplastic nodules: arterial phase enhancement at CT and MR imaging with whole explant pathologic correlation: case report. Radiology 1998, 209:461–464.

    PubMed  CAS  Google Scholar 

  18. International Working Party: Terminology of nodular lesions of the liver. Hepatology 1995, 22:983–993. This is the definitive report on the pathologic features of nodules in the cirrhotic liver.

    Google Scholar 

  19. Anthony PP: Liver cell dysplasia: What is its significance? Hepatology 1987, 7:394–395.

    Article  Google Scholar 

  20. Watanabe S, Okita K, Harada T: Morphologic studies of the liver cell dysplasia. Cancer 1983, 51:2197–2205.

    Article  PubMed  CAS  Google Scholar 

  21. Kojiro M: Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004, 10(Suppl 1):S3-S8. This article clearly discusses the Japanese pathologists’ understanding of the correlation between morphology and early HCC.

    Article  PubMed  Google Scholar 

  22. Abbitt PL: Ultrasonography of the liver: an update on new applications. Clin Liver Dis 2002, 6:17–28.

    Article  PubMed  Google Scholar 

  23. Nicolau C, Bianchi L, Vilana R: Gray-scale ultrasound in hepatic cirrhosis and chronic hepatitis: diagnosis, screening, and intervention. Semin Ultrasound CT MR 2002, 23:3–18.

    Article  PubMed  Google Scholar 

  24. Choi BI: The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl 2004, 10(Suppl 1):S20-S25.

    Article  PubMed  Google Scholar 

  25. Hohmann J, Albrecht T, Hoffmann CW, Wolf KJ: Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol 2003, 46:147–159.

    Article  PubMed  CAS  Google Scholar 

  26. Itai Y, Matsui O: Blood flow and liver imaging. Radiology 1997, 202:306–314.

    PubMed  CAS  Google Scholar 

  27. Oliver JH III, Baron RL, Federle MP, Rockette HE Jr: Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 1996, 167:71–77.

    PubMed  Google Scholar 

  28. O’Riordan E, Haider MA, O’Malley ME, et al.: Manually respiratory-triggered single-shot fast spin-echo: a non-breath-hold T2-weighted method for liver lesion detection. Can Assoc Radiol J 2003, 54:289–295.

    PubMed  Google Scholar 

  29. Numminen K, Halavaara J, Isoniemi H, et al.: Magnetic resonance imaging of the liver: true fast imaging with steady state free precession sequence facilitates rapid and reliable distinction between hepatic hemangiomas and liver malignancies. J Comput Assist Tomogr 2003, 27:571–576.

    Article  PubMed  Google Scholar 

  30. Bruix J, Sherman M, Llovet JM, et al.: Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001, 35:421–430. This is the first consensus statement on the management of HCC and describes an algorithm for the use of liver biopsy in the diagnosis. This algorithm is extensively followed here.

    Article  PubMed  CAS  Google Scholar 

  31. Levy I, Greig PD, Gallinger S, et al.: Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001, 234:206–209.

    Article  PubMed  CAS  Google Scholar 

  32. Torzilli G, Minagawa M, Takayama T, et al.: Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999, 30:889–893.

    Article  PubMed  CAS  Google Scholar 

  33. Trevisani F, D’Intino PE, Morselli-Labate AM, et al.: Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001, 34:570–575. This study clearly show that AFP is a poor screening test for HCC.

    Article  PubMed  CAS  Google Scholar 

  34. Lok A S F, Lai C-L: Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989, 9:110–115.

    Article  PubMed  CAS  Google Scholar 

  35. Di Bisceglie AM, Hoofnagle JH: Elevations of serum alphafetoprotein levels in patients with chronic hepatitis B. Cancer 1989, 64:2117–2120.

    Article  Google Scholar 

  36. Weitz IC, Liebman HA: Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 1993, 18:990–997.

    Article  PubMed  CAS  Google Scholar 

  37. Marrero JA, Su GL, Wei W, Emick D, et al.: Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003, 37:1114–1121.

    Article  PubMed  CAS  Google Scholar 

  38. Nomura F, Ishijima M, Kuwa K, et al.: Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. Am J Gastroenterol 1999, 94:650–654.

    Article  PubMed  CAS  Google Scholar 

  39. Kumada T, Nakano S, Takeda I, et al.: Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 1999, 30:125–130.

    Article  PubMed  CAS  Google Scholar 

  40. Sato Y, Nakata K, Kato Y, et al.: Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993, 328:1802–1806.

    Article  PubMed  CAS  Google Scholar 

  41. Shiraki K, Takase K, Tameda Y, et al.: A clinical study of lectinreactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 1995, 22:802–807.

    Article  PubMed  CAS  Google Scholar 

  42. Taketa K, Endo Y, Sekiya C, et al.: A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993, 53:5419–5423.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Toronto and University Health Network, Toronto General Hospital, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada

    Morris Sherman MB, BCh, PhD, FRCP(C)

Authors
  1. Morris Sherman MB, BCh, PhD, FRCP(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherman, M. Approaches to the diagnosis of hepatocellular carcinoma. Curr Gastroenterol Rep 7, 11–18 (2005). https://doi.org/10.1007/s11894-005-0060-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-005-0060-7

Keywords

Search

Navigation